IRVING, Texas, May 11 /PRNewswire-FirstCall/ -- Carrington Laboratories, Inc. , a research-based, biopharmaceutical and consumer products company, will hold its quarterly conference call to discuss third quarter results on Tuesday, May 15, 2007, at 4:30 p.m. Eastern Time (3:30 p.m. Central Time). First quarter unaudited financial results will be released earlier the same day.
Investors are invited to listen to the conference call by dialing 800-901-5248 in the US or 617-786-4512 internationally. The pass code is 51484513. The call is also being webcast by CCBN and can be accessed at Carrington’s web site at www.carringtonlabs.com.
The webcast is also being distributed through the Thomson StreetEvents Network to both institutional and individual investors. Individual investors can listen to the call at www.fulldisclosure.com, Thomson/CCBN’s individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson’s password-protected event management site, StreetEvents (www.streetevents.com).
About Carrington
Carrington Laboratories, Inc. is an ISO 9001-certified, research-based biopharmaceutical company currently utilizing naturally-occurring complex carbohydrates to:
-- manufacture and market products for mucositis, radiation dermatitis, wound and oral care; -- manufacture and market the nutraceutical and cosmetic raw materials Manapol(R) and Hydrapol(TM); and, -- market consumer products under various brands.
Carrington Laboratories, Inc.
CONTACT: Maria Mitchell of Carrington Laboratories, Inc., +1-972-518-1300,or mmitchell@carringtonlabs.com
Web site: http://www.carringtonlabs.com//
